Effect of dialytic phosphate reduction rate on mortality in maintenance hemodialysis patients: a matched case-control study

被引:0
|
作者
Yang, Shuixiu [1 ,2 ]
Diao, Zongli [1 ]
Liu, Wenhu [1 ]
Guo, Wang [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Nephrol, Beijing 100050, Peoples R China
[2] Guiyang Publ Hlth Clin Ctr, Blood Purificat Ctr, Guiyang 550001, Guizhou, Peoples R China
关键词
Phosphate reduction rate; Maintenance hemodialysis; All-cause death; Cardiocerebrovascular death;
D O I
10.1186/s12882-023-03199-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPhosphates, similar to urea, are small molecular substances that can be cleared during dialysis. Dialytic phosphate reduction rate (PRR) may, to some extent, be related to the relative amount of phosphates cleared during dialysis. However, few studies have evaluated the associations between PRR and mortality in maintenance hemodialysis (MHD) patients. In this study, we investigated the association between PRR and clinical outcomes in MHD patients.MethodsThis was a retrospective, matched case-control study. Data were collected from the Beijing Hemodialysis Quality Control and Improvement Center. Patients were divided into four groups according to PRR quartile. Age, sex, and diabetes were matched between the groups. The primary outcome was all-cause death, and the secondary outcome was cardiocerebrovascular death.ResultsThe study cohort comprised 4063 patients who were divided into four groups according to the PRR quartile: group PRR1 (< 48.35%), group PRR2 (48.35% - 54.14%), group PRR3 (54.14% - 59.14%), and group PRR4 (>= 59.14%). We enrolled 2172 patients (543 in each study group) by case-control matching. The all-cause death rates were as follows: group PRR1: 22.5% (122/543), group PRR2: 20.1% (109/543), group PRR3: 19.3% (105/543), and group PRR4: 19.3% (105/543). No significant differences in all-cause and cardiocerebrovascular death rates according to the Kaplan-Meier survival curves were found between the groups (log-rank test, P > 0.05). Multivariable Cox regression analysis revealed no significant differences in all-cause and cardiocerebrovascular death rates between the four groups (P = 0.461; adjusted hazard ratio, 0.99; 95% confidence interval, 0.97 - 1.02 versus P = 0.068; adjusted hazard ratio, 0.99; 95% confidence interval, 0.97 - 1.00, respectively).ConclusionsDialytic PRR was not significantly associated with all-cause death and cardiocerebrovascular death in MHD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effect of dialytic phosphate reduction rate on mortality in maintenance hemodialysis patients: a matched case–control study
    Shuixiu Yang
    Zongli Diao
    Wenhu Liu
    Wang Guo
    BMC Nephrology, 24
  • [2] Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study
    Liu, Yuqiu
    Zhang, Xiaoliang
    Xie, Xiaotong
    Yang, Xin
    Liu, Hong
    Tang, Rining
    Liu, Bicheng
    RENAL FAILURE, 2021, 43 (01) : 406 - 416
  • [3] Long-COVID in hemodialysis patients: a matched case-control prospective study
    Han, Maggie
    Wang, Lin-Chun
    Ren, Sarah
    Tisdale, Lela
    Dong, Zijun
    Nze, Chidiadi
    Thwin, Ohnmar
    Kotanko, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1371 - I1373
  • [4] Long-COVID in hemodialysis patients: a matched case-control prospective study
    Han, Maggie
    Wang, Lin-Chun
    Ren, Sarah
    Tisdale, Lela
    Dong, Zijun
    Nze, Chidiadi
    Thwin, Ohnmar
    Kotanko, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [5] Determinants of coronary artery disease in nondiabetic hemodialysis patients: A matched case-control study
    Zumrutdal, Aysegul
    Baltali, Mehmet
    Micozkadioglu, Hasan
    Torun, Dilek
    Sezer, Siren
    Nurhan Ozdemir, F.
    Haberal, Mehmet
    RENAL FAILURE, 2007, 29 (01) : 67 - 71
  • [6] A Matched Case-Control Study of Noncholesterol Sterols and Fatty Acids in Chronic Hemodialysis Patients
    Vecka, Marek
    Dusejovska, Magdalena
    Stankova, Barbora
    Rychlik, Ivan
    Zak, Ales
    METABOLITES, 2021, 11 (11)
  • [7] Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study
    Bostom, AG
    Shemin, D
    Lapane, KL
    Sutherland, P
    Nadeau, MR
    Wilson, PWF
    Yoburn, D
    Bausserman, L
    Tofler, G
    Jacques, PF
    Selhub, J
    Rosenberg, IH
    ATHEROSCLEROSIS, 1996, 125 (01) : 91 - 101
  • [8] Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein(a) excess in maintenance dialysis patients: A matched, case-control study
    Bostom, AG
    Shemin, D
    Lapane, K
    Bausserman, L
    Tofler, G
    Wilson, PWF
    Selhub, J
    Rosenberg, IH
    CIRCULATION, 1996, 93 (03) : P39 - P39
  • [9] Relationship of sKlotho with hemoglobin level in patients undergoing maintenance hemodialysis: a case-control study
    Liu, Qi-Feng
    Sun, Zhuo-Yi
    Tang, Xiao-Fang
    Yu, Li-Xia
    Li, Sha-Sha
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2025, 16
  • [10] Association of phase angle with sarcopenia in patients undergoing maintenance hemodialysis: A case-control study
    Alirezaei, Amirhesam
    Miladipour, Amirhossein
    Asgari, Navid
    Latifi, Marzieh
    Fazeli, Seyed Amirhossein
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2024, 29 (01):